236 related articles for article (PubMed ID: 27394186)
1. The effects of ripasudil (K-115), a Rho kinase inhibitor, on activation of human conjunctival fibroblasts.
Futakuchi A; Inoue T; Fujimoto T; Inoue-Mochita M; Kawai M; Tanihara H
Exp Eye Res; 2016 Aug; 149():107-115. PubMed ID: 27394186
[TBL] [Abstract][Full Text] [Related]
2. Effects of Ripasudil, a Rho-Kinase Inhibitor, on Scar Formation in a Mouse Model of Filtration Surgery.
Ko JA; Komatsu K; Minamoto A; Kondo S; Okumichi H; Hirooka K; Kiuchi Y
Curr Eye Res; 2023 Sep; 48(9):826-835. PubMed ID: 37216470
[TBL] [Abstract][Full Text] [Related]
3. An in vitro study of scarring formation mediated by human Tenon fibroblasts: Effect of Y-27632, a Rho kinase inhibitor.
Ibrahim DG; Ko JA; Iwata W; Okumichi H; Kiuchi Y
Cell Biochem Funct; 2019 Mar; 37(2):113-124. PubMed ID: 30773659
[TBL] [Abstract][Full Text] [Related]
4. Rosiglitasone and ROCK Inhibitors Modulate Fibrogenetic Changes in TGF-β2 Treated Human Conjunctival Fibroblasts (HconF) in Different Manners.
Oouchi Y; Watanabe M; Ida Y; Ohguro H; Hikage F
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298955
[TBL] [Abstract][Full Text] [Related]
5. Potential role of Rho-associated protein kinase inhibitor Y-27632 in glaucoma filtration surgery.
Honjo M; Tanihara H; Kameda T; Kawaji T; Yoshimura N; Araie M
Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5549-57. PubMed ID: 18055804
[TBL] [Abstract][Full Text] [Related]
6. Human anti-transforming growth factor-beta2 antibody: a new glaucoma anti-scarring agent.
Cordeiro MF; Gay JA; Khaw PT
Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2225-34. PubMed ID: 10476787
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Chitosan/Aptamer Targeting TGF-β Receptor II Thermo-Sensitive Gel for Scarring in Rat Glaucoma Filtration Surgery.
Zhu X; Xu D; Zhu X; Li L; Li H; Guo F; Chen X; Tan Y; Xie L
Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5465-76. PubMed ID: 26284552
[TBL] [Abstract][Full Text] [Related]
8. Valproic acid suppresses collagen by selective regulation of Smads in conjunctival fibrosis.
Seet LF; Toh LZ; Finger SN; Chu SW; Stefanovic B; Wong TT
J Mol Med (Berl); 2016 Mar; 94(3):321-34. PubMed ID: 26507880
[TBL] [Abstract][Full Text] [Related]
9. Molecular Mechanisms Underlying the Filtration Bleb-Maintaining Effects of Suberoylanilide Hydroxamic Acid (SAHA).
Futakuchi A; Inoue T; Fujimoto T; Kuroda U; Inoue-Mochita M; Takahashi E; Ohira S; Tanihara H
Invest Ophthalmol Vis Sci; 2017 Apr; 58(4):2421-2429. PubMed ID: 28448670
[TBL] [Abstract][Full Text] [Related]
10. SB-431542 inhibition of scar formation after filtration surgery and its potential mechanism.
Xiao YQ; Liu K; Shen JF; Xu GT; Ye W
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1698-706. PubMed ID: 19098325
[TBL] [Abstract][Full Text] [Related]
11. Inhibition by all-trans-retinoic acid of transforming growth factor-β-induced collagen gel contraction mediated by human tenon fibroblasts.
Liu Y; Kimura K; Orita T; Teranishi S; Suzuki K; Sonoda KH
Invest Ophthalmol Vis Sci; 2014 Jun; 55(7):4199-205. PubMed ID: 24894398
[TBL] [Abstract][Full Text] [Related]
12. Time Course of Conjunctival Hyperemia Induced by a Rho-kinase Inhibitor Anti-glaucoma Eye Drop: Ripasudil 0.4.
Terao E; Nakakura S; Fujisawa Y; Fujio Y; Matsuya K; Kobayashi Y; Tabuchi H; Yoneda T; Fukushima A; Kiuchi Y
Curr Eye Res; 2017 May; 42(5):738-742. PubMed ID: 27911106
[TBL] [Abstract][Full Text] [Related]
13. Suppression of transforming growth factor-β effects in rabbit subconjunctival fibroblasts by activin receptor-like kinase 5 inhibitor.
Sapitro J; Dunmire JJ; Scott SE; Sutariya V; Geldenhuys WJ; Hewit M; Yue BY; Nakamura H
Mol Vis; 2010 Sep; 16():1880-92. PubMed ID: 21031133
[TBL] [Abstract][Full Text] [Related]
14. DNA methyltransferase inhibitor suppresses fibrogenetic changes in human conjunctival fibroblasts.
Yonemura H; Futakuchi A; Inoue-Mochita M; Fujimoto T; Takahashi E; Tanihara H; Inoue T
Mol Vis; 2019; 25():382-390. PubMed ID: 31523116
[TBL] [Abstract][Full Text] [Related]
15. YAP/TAZ Are Essential for TGF-β2-Mediated Conjunctival Fibrosis.
Futakuchi A; Inoue T; Wei FY; Inoue-Mochita M; Fujimoto T; Tomizawa K; Tanihara H
Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):3069-3078. PubMed ID: 30025139
[TBL] [Abstract][Full Text] [Related]
16. Contractility as a prerequisite for TGF-beta-induced myofibroblast transdifferentiation in human tenon fibroblasts.
Meyer-ter-Vehn T; Sieprath S; Katzenberger B; Gebhardt S; Grehn F; Schlunck G
Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4895-904. PubMed ID: 17065504
[TBL] [Abstract][Full Text] [Related]
17. The involvement of the rho-kinase pathway and its regulation in cytokine-induced collagen gel contraction by hyalocytes.
Hirayama K; Hata Y; Noda Y; Miura M; Yamanaka I; Shimokawa H; Ishibashi T
Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):3896-903. PubMed ID: 15505034
[TBL] [Abstract][Full Text] [Related]
18. Critical role of the Rho-kinase pathway in TGF-beta2-dependent collagen gel contraction by retinal pigment epithelial cells.
Miura M; Hata Y; Hirayama K; Kita T; Noda Y; Fujisawa K; Shimokawa H; Ishibashi T
Exp Eye Res; 2006 May; 82(5):849-59. PubMed ID: 16310190
[TBL] [Abstract][Full Text] [Related]
19. All‑trans‑retinoic acid modulates TGF‑β‑induced apoptosis, proliferation, migration and extracellular matrix synthesis of conjunctival fibroblasts by inhibiting PI3K/AKT signaling.
Liang L; Wang X; Zheng Y; Liu Y
Mol Med Rep; 2019 Sep; 20(3):2929-2935. PubMed ID: 31322252
[TBL] [Abstract][Full Text] [Related]
20. Rho kinase inhibitor AMA0526 improves surgical outcome in a rabbit model of glaucoma filtration surgery.
Van de Velde S; Van Bergen T; Vandewalle E; Kindt N; Castermans K; Moons L; Stalmans I
Prog Brain Res; 2015; 220():283-97. PubMed ID: 26497796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
